Skip to content
AppDues
Log in
Contact salesSign up

Shotsy and the GLP-1 Tracking App: A Trust-First Growth Case Study

Shotsy is a mobile app for tracking GLP-1 medications, built by Aja Beckett after her own experience with GLP-1s made the gap in existing tracking tools obvious. The app's stated priorities are authenticity, user-first design, and helping people on similar health paths. This case study walks through the decisions behind it: what stayed free, how it found users, and why trust rather than virality shaped the roadmap. The account below follows the story as Aja told it on the Launched podcast; treat specific figures and outcomes as her own account rather than independently verified results.

Authenticity before anything else

Earlier indie experiments chased trends or addressed generic needs. Shotsy started from a specific one: the builder was taking GLP-1s and needed a better way to track them. That origin set the feature priorities — recording doses, working through side effects, and arriving at doctor visits with information that supports better decisions.

The monetization stance followed the same logic. The core functions are free, and the source quotes the builder saying "All the important stuff is free." Premium features are framed as thank-you bonuses rather than locked essentials. Demand showed up in behavior: users shared the app, screenshotted it, and asked for it by name.

For a builder reading this, the test is not "copy the free tier." It is whether the free experience alone solves the core job. If it does not, a thank-you premium layer has nothing to sit on top of.

Start small, stay smart

Traction appeared before launch: spreadsheet threads, subreddit discussion, and beta slots that filled within minutes. The response was to keep scope narrow rather than raise money immediately or launch in every market at once. Effort went into refining App Store optimization and staying focused on App Store search as the acquisition channel, with value delivered from the first session.

Shotsy was the seventh app attempt and the first to stick. The source's explanation is not that it was the flashiest, but that it met people where they were. Users were not shopping for a generic "weight loss app"; they wanted support for a personal health journey.

A useful reading of the seventh-app detail: the earlier attempts were not wasted, but they also were not validation. What changed was the specificity of the problem and the builder's direct knowledge of it.

Building trust, not virality

No social loop was designed into the product, yet one formed. Screenshots of the app's colorful charts circulated in communities and drove word-of-mouth growth. According to the source, no money has been spent on ads; instead, effort went into features that help users stay consistent and feel supported. The app is described as usable free forever, with premium features positioned as bonuses.

A small pre-seed round was raised later, framed as protecting what had already been built as competitors appeared, with the goal of keeping the most trusted app available to the people who rely on it.

Two cautions for readers. First, "no ad spend" describes one app's path, not a rule that paid acquisition is unnecessary. Second, a pre-seed round raised to defend a position is a different decision from raising to accelerate growth; Aja's round was the former.

What to take from Shotsy's story

The through-line is empathy-driven building: start from a problem you understand firsthand, keep the essential experience free, earn distribution through the product itself, and raise money only when it protects something worth keeping. If you are working on something personal, the practical checklist is:

  • Does the free experience fully solve the core job?
  • Is the acquisition channel narrow enough to master (here, App Store search)?
  • Would users share the product without a built-in social loop?
  • If you raise, is the goal defense or acceleration — and does the amount match it?

The source presents this as one founder's account, not a benchmark. Use it as a set of questions to test against your own app.

Shotsy's choices and the question to ask before copying them
Shotsy choice (as captured)Question for your app
Core tracking features free; premium as thank-you bonusesDoes the free tier alone complete the core job?
Focus on App Store search and ASOIs one acquisition channel narrow enough to master first?
No ad spend; growth via shared screenshotsWould users share this without a designed social loop?
Small pre-seed round raised after tractionIs the raise for defense or acceleration, and does the size match?
Seventh app attempt before tractionIs the current idea specific to a problem you know firsthand?

Rows summarize the captured interview account; they are not verified performance benchmarks.

Frequently asked questions

What is Shotsy?

Shotsy is a mobile app for tracking GLP-1 medications, created by Aja Beckett. It focuses on dose tracking, side effects, and information useful in doctor conversations, with the core features offered free.

Is Shotsy really free?

Aja describes the app as usable free forever, with the important features free and premium features positioned as thank-you bonuses rather than locked essentials. Check the app's current listing for the present terms.

Did Shotsy grow without advertising?

According to Aja, no money has been spent on ads; growth came from users sharing screenshots in communities. That is one app's reported path, not evidence that paid acquisition is unnecessary in general.

Why is Shotsy called the seventh app?

Aja says Shotsy was her seventh app and the first to gain traction, after earlier indie experiments that had promise but did not stick. The difference she describes is specificity: it addressed a problem she knew firsthand.